Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tet2 deficiency drives pathobiont translocation triggering Tc1 cell autoimmune hepatitis

ABSTRACT: Tet2 deficiency drives pathobiont translocation triggering Tc1 cell autoimmune hepatitis

PROVIDER: PRJNA831834 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18912911.fastq.gz	Fastqsanger.gz
	SRR18912912.fastq.gz	Fastqsanger.gz
	SRR18912913.fastq.gz	Fastqsanger.gz
	SRR18912914.fastq.gz	Fastqsanger.gz
	SRR18912915.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 14

Similar Datasets

Tet2 deficiency drives pathobiont translocation triggering Tc1 cell autoimmune hepatitis

Project description:The triggers that drive interferon-g (IFNg)-producing CD8 T cell (Tc1 cell)-mediated autoimmune hepatitis (AIH) remain obscure. Here we show that lack of hematopoietic Tet methylcytosine dioxygenase 2 (Tet2), an epigenetic regulator associated with autoimmunity, results in the development of microbiota-dependent AIH-like pathology, accompanied by hepatic enrichment of aryl hydrocarbon receptor (AhR) ligand-producing pathobionts and rampant Tc1 cell immunity. We report that AIH-like disease development is dependent on both IFNg and AhR signaling, as blocking either reverts ongoing AIH-like pathology. Illustrating the critical role of AhR ligand-producing pathobionts in this condition, hepatic translocation of the AhR ligand indole-3-aldehyde (I3A)-releasing Lactobacillus reuteri is sufficient to trigger AIH-like pathology. Finally, we demonstrate that I3A is required for L. reuteri-induced Tc1 cell differentiation in vitro and AIH-like pathology in vivo, both of which are restrained by Tet2 within CD8 T cells. This AIH-disease model may contribute to the development of therapeutics to alleviate AIH.

2022-04-28 | GSE201459 | GEO

Project description:Tet2 deficiency drives pathobiont translocation triggering Tc1 cell autoimmune hepatitis

| PRJNA830441 | ENA

The Enemy Lies Within: Spontaneous Translocation of a Gut Pathobiont Drives Autoimmunity

Project description:Spontaneous Translocation of a Gut Pathobiont Drives Autoimmunity

| PRJEB24586 | ENA

Translocation of a gut pathobiont drives autoimmunity in mice and humans

Project description:Translocation of a gut pathobiont drives autoimmunity in mice and humans

| PRJEB24587 | ENA

Tc1 and Tc2 secretion proteome evaluation

Project description:The goal of this project is to dissect the mechanism by which Tc1 and Tc2 effector subtypes effect cell physiology in vitro. I utilized cellular proteomics to determine Tc1 and Tc2 secretion patterns and identify inflammatory factors that regulate cell polarization and physiology in vitro.

2022-02-15 | PXD011757 | Pride

gene expression in Tc1 vs Tc9 cells

Project description:gene expression in Tc1 vs Tc9 cells

2018-05-03 | GSE100422 | GEO

Curtobacterium sp. TC1

Project description:Curtobacterium sp. TC1 Genome sequencing

| PRJNA748736 | ENA

Gene expression in Tc1 vs Tc9 cell at day 5 polarization

Project description:T cells from spleen and lymphnode were isolated with EasySep Mouse CD8+ T Cell Isolation kit. Isolated CD8+ T cells were stimulated and cultured with plate-bound anti-CD3 and soluble anti CD28 antiboies in Tc1 or Tc9 cell polarizing conditios. After 3-day of polarization, cell were transferred into a new well and culture for another 2-day. on day 5 after seeding, Tc1 and Tc9 cells were collected and sequenced. We used microarrays to detail the global programme of gene expression of Tc1 and Tc9 cells at day 5 polarization.

2024-01-07 | GSE239842 | GEO

RNA sequence of gene expression in tumor-infiltrating Tc1 and Tc9 cells

Project description:we use RNA sequence to detect the global gene expression in tumor-infiltrating Tc1 and Tc9 cells after being adoptively transferred in vivo

2021-12-31 | GSE176291 | GEO

Mesomycoplasma ovipneumoniae strain:TC1

Project description:Mesomycoplasma ovipneumoniae strain:TC1 Genome sequencing and assembly

| PRJNA253501 | ENA